SMHP Pharmaceuticals Inc.

SMHP Pharmaceuticals Inc. is a pharmaceutical and regulatory consultancy firm serving the pharmaceutical, biopharmaceutical, and medical device industries. Initially established in 1995 as S.M.H.P. Marketing & Consultancy, and incorporated as SMHP Pharmaceuticals in 2012, SMHP helps provide the Filipino people with exceptional medicines at an extremely affordable price. The Philippines is the fastest growing economy among ASEAN nations. Industry is growing at an average of 6%, with the branded generics growing at an average rate of 11%. SMHP has registered over 1000 products of finished formulations, including WHO-Pre Qualified registrations, and is currently partnered with over 80 leading manufacturers from various countries worldwide: including India, China, Greece, Spain, Switzerland, and the UK, for the registration of their products in the Philippines. SMHP is the premier company to offer this consultancy-based service in the Philippines and is also the first company to import and distribute Indian generics to the Philippine market. With its emphasis on boldness and unsurpassed will to provide to the Filipino, it pioneers the market with affordable anti-infectives, recombinant Human Insulin, and various oncology medicines. SMHP is also the first pharmaceutical company to introduce generic anti-retrovirals into the mainstream Philippine government requirements. With successes and a clear vision, SMHP will continue to pave the path in making sure that no Filipino is deprived of their right to healthcare and an improved life at a reasonable price.